TMD
34
3
4
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
93.8%
+7.2% vs benchmark
6%
2 trials in Phase 3/4
0%
0 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (34)
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular Disorders
Pain, Central Sensitization and Psychoemotional State in Patients With Chronic Masticatory Muscle Pain
Conventional, Additive and Subtractive Occlusal Splints for TMDs
Two Treatment Modalities for Myogenous Temporomandibular Disorders
Pain Neuroscience Education, Motor Imagery and Action Observation in Patients With Chronic Temporomandibular Disorders.
Arthroscopic Anterior Release Versus Discectomy as Treatments for Temporomandibular Joint Disc Displacement With Reduction
Effects Exercises in Temporomandibular Joint Disorders on Pain, Joint and Tongue Functions
Effects of Core Strengthening Exercises for Treating TMD
ARS vs ARS With Arthrocentesis and PRP Injection in DDWR
Exploring the Relationship Between Occlusion and Degenerative TMJ Disorders: A Comparative Clinical Study
Exploration of the Utility of Dental-dedicated MRI for Dentistry
Treatment Outcomes in Patients With Muscular Temporo-mandibular Joint Disorders
Is PNF Application Effective on Temporomandibular Dysfunction
Digital Occlusal Analysis and Enamel Wear Assessment in Temporomandibular Disorder Patients Treated with Fully Digital Versus Conventional Stabilization Splints
AMOUNT OF INTRAORAL OCCLUSAL ADJUSTMENTS IN OCCLUSAL SPLINTS FABRICATED USING FULLY DIGITAL VERSUS COMBINED DIGITAL WORKFLOW IN TMD PATIENTS
Impact of Breather Device on Ventilatory Effort in Patient With MTMD
Clinical Performance of CAD/CAM Splint Materials
Validation of a Novel Cortical Biomarker Signature for Pain
Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region